Background: Fracture incidence appears to be increased in HIV+ individuals, especially after ART. Dual-energy x-ray absorptiometry (DXA) characterizes bone mineral density (BMD) and is predictive of fracture, but is not widely available in resource-constrained settings (RCS). Quantitative ultrasound (QUS) assesses bone quality by measuring speed of an ultrasound wave (SOS) through bone; lower SOS is predictive of increased fracture risk in older women. We compared bone quality by QUS at the radius in HIV+ and HIV- women in Rwanda.
Methods: Cross sectional study of 646 ART-naïve HIV+ and 211 HIV- women. Demographic, anthropomorphic, laboratory, co-morbidity, and socioeconomic data were collected. A Sunlight Omnisense 7000 QUS (BeamMed Ltd, Israel) was utilized to measure SOS at the radius using 2 trained technicians. Inter-observer agreement assessed on a subset (N=56) was high (kappa>0.90). Mean SOS±SD, T-scores (compared to SOS from young women), Z- scores (compared to SOS from women of same age) using the manufacturer’s reference based upon American norms were calculated.
Results: HIV+ women were younger than HIV- women (35±7 vs 42+10 years, p<0.001), had more chronic diarrhea (23% vs 8%, p<0.001), and lower albumin (3.4±0.7 vs. 3.9±0.5 g/dL, p<0.001), but similar body mass index (BMI, 21.5±3.7 vs 21.3±3.8 kg/m2, p=0.51). Among HIV+ women, mean CD4+ T cell count was 285 (SD=166) cells/mm3 and 30% had an AIDS defining illness. Average SOS was slightly higher in HIV+ than HIV- women (4024.4±110.5 vs. 4003.9±113.1 m/s, p= 0.02); this group difference was attenuated by adjustment for age (p=0.04) but not BMI (Table). SOS T- and Z-scores did not differ pre or post adjustment for BMI between HIV infection groups. Among HIV+ women, SOS did not differ by CD4+ count <200 vs. ≥200cells/mm3: 4016±117 vs 4028±107m/s, respectively (p=0.19).
Conclusions: Despite having relatively advanced HIV disease, ART-naïve, predominantly premenopausal Rwandan women did not have worse bone quality by radius QUS than uninfected controls. Our results are consistent with data from a South African study that found that BMD by DXA were similar in ART-naïve HIV+ women and uninfected controls. Unlike DXA, radius QUS is uninfluenced by weight or body fat, is portable, inexpensive, and does not emit radiation or require high-level training. QUS may be an ideal modality to track bone quality and fracture risk after ART-initiation in HIV+ individuals in RCS.
| Characteristics | HIV+ (N=646) |
HIV- (N=211) |
P value | P value Adjusted for Age |
P value Adjusted for BMI |
| Average SOS (m/s) | 4024.4±110.5 | 4003.9±113.1 | 0.02 | 0.04 | 0.02 |
| T score | -0.07±1.37 | -0.18±1.43 | 0.30 | – | 0.31 |
| Z score | 0.09±1.35 | 0.10±1.38 | 0.90 | – | 0.89 |
Data are presented as Mean±SD; *The p-value is from ANOVA; ART, antiretroviral therapy; HIV+, HIV-infected; HIV, HIV-uninfected; BMI, Body mass index; SOS, ultrasound wave.